Small Molecule Allosteric Inhibitor of HIPK2 as a Novel Therapy against Kidney Fibrosis
1Icahn School of Medicine at Mount Sinai, New York, New York
2Rila Therapeutics Inc, South San Francisco, California
3ShangPharma Innovations Inc, South San Francisco, California
Correspondence: Dr. John C. He or Dr. Kyung Lee, email: [email protected] or [email protected]
Comments (0)